Real-World Effectiveness of Therapy With Rosuvastatin Combined With Fenofibric Acid in a Sample of Colombian Patients With Mixed Dyslipidemia.
Manuel E Machado-DuqueAndrés Gaviria-MendozaJorge Enrique Machado-AlbaPublished in: Journal of primary care & community health (2021)
The combination of rosuvastatin + fenofibric acid is an effective option in patients with mixed dyslipidemia and high cardiovascular risk, providing a therapeutic alternative for those conditions that require it.